NCT06079398: A Clinical Trial to Evaluate Efficacy and Safety of TransCon CNP Compared With Placebo in Infants (0 to <2 Years of Age) With Achondroplasia
- State
- Under way
- Phase
- Phase 2
- People
- 72 planned
- Started
- 23 Jan 2024
- Primary completion
- Dec 2027
- Arms
- Navepegritide
- Results
- None posted
- 12 Oct 2023: Trial registered
- 23 Jan 2024: Trial started